Appendix 4C, “December 2018 Quarterly Update” was lodged with the Australian Securities Exchange on 31st January.
View the Appendix 4C.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell